Divis Laboratories Ltd - Share Price
DIVISLAB
Divis Laboratories LtdFinancials
Divis Laboratories LtdNews & Updates
Nifty Pharma reverses bearish trend, holds steady; Torrent Pharma, Alkem, Divis Lab led the pack; Lu
Jun 14,2021 02:43 PM
India continues to report a sustained slide in the daily new COVID cases.
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 677.10 | 72.90 | 162,494.96 | 327.39 | 1.11 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,388.05 | 59.58 | 116,462.39 | 487.93 | 0.46 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,461.35 | 41.54 | 90,816.62 | 311.50 | 0.46 | 3,313.50 | 1,020.99 |
| Cipla Ltd | 976.15 | 31.89 | 78,729.89 | 413.41 | 0.51 | 3,173.39 | 247.09 |
| Cadila Healthcare Ltd | 655.40 | 41.16 | 67,075.62 | 464.70 | 0.53 | 1,949.70 | 124.49 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Divis Laboratories LtdSummary & Reports
Divis Laboratories Ltd is an India based manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates. The company is engaged in manufacture of leading generic compounds, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global innovator companies. Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. The company has four ... More
Registered Office
1-72-23(P)/DIVIS/303 Divi Towe,Cyber Hills Gachibowli,Hyderabad, Telangana,500032
Tell. : +91-40-23786300/23786352/400
Website : http://www.divislaboratories.com
Email : mail@divislabs.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com
Reports by divis-laboratories-ltd-share-price
Latest Release by divis-laboratories-ltd-share-price
Result Express
Jun 14, 2021 08:08 PM
The company’s standalone revenue stood at Rs1,342.92cr, up 29.39% yoy and 4.51% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 51.95% |
| Total Promoter | 51.95% |
| Non Promoter | - |
| Institutions | 36.61% |
| Non-Institutions | 11.45% |
| Total Non-Promoter | 48.05% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
29 May 2021
Annc. Date
21 May 2021
DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More
Purpose
Board Meeting
Exp. Date
06 Feb 2021
Annc. Date
23 Jan 2021
DIVIs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is... More
